Tokyo, July 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062197) titled 'Short-term ubiquinol supplementation on exercise performance and heart rate' on July 10.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo

Primary Sponsor: Institute - Juntendo University, Graduate School of Health and Sports Science

Condition: Condition - Healthy people Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The purpose of this study is to assess the effect of short-term ubiquinol supplementation on exercise performance and heart rate in male collegiate distance runners. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - 300 mg/d Ubiquinol, 1 week Interventions/Control_2 - Placebo, 1 week

Eligibility: Age-lower limit - 18 years-old = Gender - Male Key inclusion criteria - 1. 16 healthy male college long-distance track and field athletes 2. Aged 18 to 25 3. Individuals in good physical condition who can safely participate in the test 4. Individuals who, prior to participating in this test, have received an explanation of the test, understand its content, and agree with its purpose 5. Individuals from whom written consent can be obtained Key exclusion criteria - 1. Individuals currently receiving medical treatment or prescription medication 2. Individuals suffering from, or with a history of, severe cardiovascular, hepatic, renal, respiratory, endocrine, or metabolic disorders 3. Individuals at risk of developing an allergy related to the test diet 4. Individuals who regularly take supplements containing coenzyme Q10 5. Individuals who smoke 6. Individuals who have donated blood (e.g., as a blood donor) in an amount exceeding 200 mL within 1 month prior to the start of this trial, or 400 mL within 3 months prior to the start of this trial 7. Individuals who have participated in another clinical trial within the past 3 months, or who are currently participating in another clinical trial 8. Any other individuals deemed ineligible by the principal investigator Target Size - 16

Recruitment Status: Recruitment status - Completed Date of protocol fixation - 2018 Year 09 Month 11 Day Date of IRB - 2018 Year 09 Month 11 Day Anticipated trial start date - 2018 Year 09 Month 12 Day Last follow-up date - 2018 Year 12 Month 02 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071176

Disclaimer: Curated by HT Syndication.